Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer by T Brown, A Boland, A Bagust, J Oyee, J Hockenhull, Y Dundar, R Dickson, VS Ramani, C Proudlove

Get full text

Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck by J Greenhalgh, A Bagust, A Boland, N Fleeman, C McLeod, Y Dundar, C Proudlove, R Shaw

Get full text

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis by J Greenhalgh, A Bagust, A Boland, C Martin Saborido, J Oyee, M Blundell, Y Dundar, R Dickson, C Proudlove, M Fisher

Get full text

Rituximab for the treatment of rheumatoid arthritis by A Bagust, A Boland, J Hockenhull, N Fleeman, J Greenhalgh, Y Dundar, C Proudlove, T Kennedy, R Moots, P Williamson, R Dickson

Get full text

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention by J Greenhalgh, A Bagust, A Boland, CM Saborido, N Fleeman, C McLeod, Y Dundar, R Dickson, C Proudlove, R Kolamunnage-Dona, M Fisher

Get full text

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention by J Greenhalgh, A Bagust, A Boland, CM Saborido, N Fleeman, C McLeod, Y Dundar, R Dickson, C Proudlove, R Kolamunnage-Dona, M Fisher

Get full text

Erlotinib for the treatment of relapsed non-small cell lung cancer by C McLeod, A Bagust, A Boland, J Hockenhull, Y Dundar, C Proudlove, H Davis, J Green, F Macbeth, J Stevenson, T Walley, R Dickson

Get full text